EUROAPI SA (EAPI.PA) Financials
EAPI.PA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 1.9 billion | 672.1 million |
2023-03-31 | 1.9 billion | 672.2 million |
2022-12-31 | 1.7 billion | 625.9 million |
2022-09-30 | 1.7 billion | 625.9 million |
EAPI.PA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | -113.3 million | 3.3 million |
2023-03-31 | -55.7 million | 3.3 million |
2022-12-31 | -18.0 million | 3.6 million |
2022-09-30 | 7.1 million | 3.6 million |
EAPI.PA Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-06-30 | 62.8 million |
2023-03-31 | 31.4 million |
2022-12-31 | -31.7 million |
2022-09-30 | -15.9 million |
EAPI.PA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 60.6 million | 15.7 million | 20.6 million |
2023-03-31 | 57.0 million | - | - |
2022-12-31 | 74.5 million | 16.2 million | 20.7 million |
2022-09-30 | 74.5 million | - | - |
EAPI.PA Shares Outstanding
EAPI.PA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 73.1 million | 13.3 million | 21.4 million | 10.7 million |
2023-03-31 | 36.6 million | 6.7 million | 21.4 million | 10.7 million |
2022-12-31 | 58.5 million | 10.4 million | 25.3 million | 10.1 million |
2022-09-30 | 13.3 million | 5.2 million | 25.3 million | 10.1 million |
EAPI.PA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 496.6 million | 402.3 million |
2023-03-31 | 249.3 million | 200.7 million |
2022-12-31 | 492.8 million | 415.9 million |
2022-09-30 | 247.6 million | 208.0 million |
EAPI.PA
Price: €2.87
52 week price:
Earnings Per Share: -2.02 EUR
P/E Ratio: 19.57
Exchange: PAR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 179608
Market Capitalization: 265.8 million